Evaluation of Optimal Number of Neoadjuvant Chemotherapy Cycles and Cytoreductive Surgery in Women with Ovarian Cancer

被引:0
|
作者
Shahrzad Sheikh Hassani
Somayeh Moradpanah
Setare Akhavan
Azamsadat Mousavi
Narges Zamani
Elahe Rezayof
机构
[1] Tehran University of Medical Sciences,Department of Obstetrics and Gynecology
[2] Ziaeian Hospital,Department of Obstetrics and Gynecology
[3] Tehran University of Medical Sciences,Department of Gynecology Oncology
[4] Tehran University of Medical Sciences,undefined
[5] Vali-E-Asr Reproductive Health Research Center,undefined
[6] Family Health Research Institute,undefined
[7] Tehran University of Medical Sciences,undefined
来源
关键词
Ovarian cancer; Neoadjuavnt chemotherapy; Interval debulking surgery; CA-125;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Primary Cytoreductive Surgery Versus Interval Debulking Surgery Following Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer: An Institutional Review
    Ahmad, Zeeshanuddin
    Jain, Amar
    Mehta, Nikhil
    Saldanha, Elroy
    Patel, Dhruv
    Desai, Sanjay M.
    [J]. INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 17 (01)
  • [42] Primary Cytoreductive Surgery Versus Interval Debulking Surgery Following Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer: An Institutional Review
    Zeeshanuddin Ahmad
    Amar Jain
    Nikhil Mehta
    Elroy Saldanha
    Dhruv Patel
    Sanjay M. Desai
    [J]. Indian Journal of Gynecologic Oncology, 2019, 17
  • [43] Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients not candidates for optimal primary surgery: Safety and effectivenes
    Miranda, Vanessa Costa
    de Sousa Fede, Angelo Bezerra
    Dos Anjos, Carlos Henrique
    da Silva, Juliana Ribeiro
    Sanchez, Fernando Barbosa
    da Silva Bessa, Lyvia Rodrigues
    Carvalho, Jesus Paula
    Abdo Filho, Elias
    Freitas, Daniela
    Borges de Barros, Laryssa Almeida
    Severino da Silva, Samantha Cabral
    Estevez-Diz, Maria Del Pilar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Neoadjuvant chemotherapy in advanced ovarian cancer: optimal patient selection and response evaluation
    Cho, Jae Hyun
    Kim, Seik
    Song, Yong Sang
    [J]. CHINESE CLINICAL ONCOLOGY, 2018, 7 (06)
  • [45] Impact of neoadjuvant chemotherapy cycles prior to interval surgery in patients with advanced epithelial ovarian cancer
    Colombo, P. E.
    Labaki, M.
    Fabbro, M.
    Bertrand, M.
    Mourregot, A.
    Gutowski, M.
    Saint-Aubert, B.
    Quenet, F.
    Rouanet, P.
    Mollevi, C.
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 223 - 230
  • [46] Relationship Between Neoadjuvant Chemotherapy and Log Odds of Positive Lymph Nodes and Their Prognostic Role in Advanced Ovarian Cancer Patients With Optimal Cytoreductive Surgery
    Hou, Yue-min
    Xue, Yan
    Yao, Jin-meng
    Feng, Fang
    An, Rui-fang
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer
    Polom, Karol
    Roviello, Giandomenico
    Generali, Daniele
    Marano, Luigi
    Petrioli, Roberto
    Marsili, Stefania
    Caputo, Edda
    Marrelli, Daniele
    Roviello, Franco
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2016, 32 (03) : 298 - 310
  • [48] Cytoreductive surgery and perioperative intraperitoneal chemotherapy in recurrent ovarian cancer
    Tentes, Antonios-Apostolos K.
    Korakianitis, Odysseas S.
    Kakolyris, Stylianos
    Kyziridis, Dimitrios
    Veliovits, Dousan
    Karagiozoglou, Chrysa
    Sgouridou, Evanthia
    Moustakas, Konstantinos
    [J]. TUMORI, 2010, 96 (03) : 411 - 416
  • [49] Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer
    Bixel, K.
    Vetter, M.
    Davidson, B.
    Berchuck, A.
    Cohn, D.
    Copeland, L.
    Fowler, J. M.
    Havrilesky, L.
    Lee, P. S.
    O'Malley, D. M.
    Salani, R.
    Valea, F.
    Secord, A. Alvarez
    Backes, F.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 156 (03) : 530 - 534
  • [50] IMPACT OF THE NUMBER OF CYCLES OF NEOADJUVANT CHEMOTHERAPY BEFORE INTERVAL DEBULKING SURGERY ON SURVIVAL IN ADVANCED STAGES OVARIAN CANCER : A MULTICENTRIC RETROSPECTIVE STUDY
    Akladios, C.
    Shrot-Sanyan, S.
    Decok, L.
    Petit, T.
    Robstock, L.
    Baldauf, J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1270 - 1271